S. François

发表

Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

P. Cony-Makhoul, C. Patte, A. Delmer, 1995, Blood.

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients

H. Cavé, P. Rohrlich, E. W. Van Den Neste, 2018, Haematologica.

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

J. Bourhis, M. Labopin, P. Chevallier, 2016, Cancer medicine.

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

R. Bouabdallah, A. Stamatoullas, S. Mareschal, 2016, Bone Marrow Transplantation.

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

J. Soulier, I. Yakoub-Agha, D. Blaise, 2011, Haematologica.

Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry

R. Bouabdallah, O. Casasnovas, C. Gisselbrecht, 1998, Bone Marrow Transplantation.

Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France.

E. Deconinck, P. Colombat, L. Sensébé, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.

A. Vekhoff, M. Labopin, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

I. Yakoub-Agha, C. Leroy, C. Decanter, 2014, Orphanet Journal of Rare Diseases.

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.

P. Pedrazzoli, D. Blaise, D. Niederwieser, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry

F. Jardin, T. Leblanc, Y. Bertrand, 2009, Pediatric blood & cancer.

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.

D. Blaise, M. Mohty, V. Bardou, 2004, Blood.

Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas

O. Dereure, S. Dalle, M. Beylot-Barry, 2014, Haematologica.

A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients

P. Hurteloup, J. Harousseau, Z. Tellier, 1998 .

Impact of Azacitidine (AZA) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Myelodysplastic Syndromes (MDS): A Large-Scale Study on Behalf of the SFGM-TC and GFM Groups

M. Robin, I. Yakoub-Agha, M. Mohty, 2011 .

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

P. Hurteloup, J. Harousseau, Z. Tellier, 1998, Blood.

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM‐TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

protocols retrospective study of 65 adults treated with the LMB pediatric Small noncleaved cell lymphoma and leukemia in adults. A

P. Cony-Makhoul, C. Patte, A. Delmer, 2011 .

Outcome Of Patients With IPSS Intermediate (int) Or High Risk Myelodysplastic Syndrome (MDS) According To Donor Availability: A Multicenter Prospective Non Interventional Study For The SFGM-TC and GFM

R. Porcher, H. Dombret, P. Fenaux, 2013 .

Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.

D. Blaise, E. Robinet, P. Tiberghien, 2002, Blood.

Intestinal derivation for digestive complications of graft versus host disease in adult patients: a case series and review of the literature

S. Thépot, N. Ifrah, M. Hunault-Berger, 2021, Trends in Transplantation.

Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access program.

S. Leprêtre, L. Fornecker, L. Ysebaert, 2015, Clinical lymphoma, myeloma & leukemia.

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

N. Kröger, S. Iacobelli, E. Tholouli, 2017, Haematologica.

transplantation hematopoietic stem cell transplantation compared with bone marrow mobilized peripheral blood - granulocyte colony-stimulating factor Increased presence of anti-HLA antibodies early after allogeneic

A. Aupérin, P. Saas, F. Garban, 2013 .

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

P. Hurteloup, J. Abgrall, P. Hervé, 1997, Blood.

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

P. Chevallier, S. Nguyen, A. Berceanu, 2021, Blood.

Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease‐free survival can be obtained using a unique consolidation course

P. Berthaud, P. Hurteloup, P. Hervé, 1996, British journal of haematology.

Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

R. Porcher, H. Dombret, M. Robin, 2015, Leukemia.

Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.

Intensive short term therapy with granulocyte‐macrophage–colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia

N. Ifrah, J. Harousseau, C. Linassier, 1999 .

Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages.

J. Jais, J. Harousseau, F. Guilhot, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage 111-IV patients

E. Deconinck, P. Colombat, L. Sensébé, 1997 .

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.

R. Houot, J. Ritz, M. Perales, 2017, Blood.

Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.

S. Chevret, I. Yakoub-Agha, E. Wattel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie-biologie.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie-biologie.

[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis].

I. Yakoub-Agha, F. Bauters, C. Decanter, 2013, Pathologie et biologie.

Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence

P. Asfar, S. Thépot, A. Kouatchet, 2018, Annals of Hematology.

Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care

P. Asfar, S. Thépot, A. Kouatchet, 2017, Transplantation.

[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

I. Yakoub-Agha, D. Blaise, F. Suarez, 2016, Bulletin du cancer.

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, M. Mohty, 2013, Haematologica.

Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high risk acute myeloid leukemia or myelodysplastic syndrome.

P. Chevallier, S. Thépot, L. Planche, 2021, Transplantation and cellular therapy.

Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation

V. Ugo, S. Thépot, N. Ifrah, 2019, Leukemia.

Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.

M. Robin, P. Chevallier, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI)

M. Mahé, S. Supiot, K. Clément-Colmou, 2017, Clinical transplantation.

Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot study.

E. Deconinck, A. Moreau, N. Milpied, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lack of Efficacy of 2-Chlorodeoxyadenoside in the Treatment of Splenic Lymphoma with Villous Lymphocytes

B. Grosbois, X. Troussard, J. Misset, 2000, Leukemia & lymphoma.

Allogeneic hematopoietic stem cell transplantation for T‐prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM‐TC)

I. Yakoub-Agha, D. Blaise, M. Mohty, 2015, European journal of haematology.

Donor cell‐derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation

V. Ugo, F. Geneviève, O. Blanchet, 2018, European journal of haematology.

Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide

P. Chevallier, M. Béné, S. Thépot, 2021, Cancer medicine.

Peripheral primitive neuroectodermal tumour after allogeneic bone marrow transplantation

J. Coindre, N. Ifrah, E. Gamelin, 1995, British journal of haematology.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Ruxolitinib Before Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Patients With myelofibrosis : a Preliminary Descriptive Report Of The JAK ALLO Study, a Phase II Trial Sponsored By Goelams-FIM In Collaboration With The Sfgmtc

R. Porcher, M. Robin, I. Yakoub-Agha, 2013 .

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients

P. Chevallier, S. Nguyen Quoc, M. Loschi, 2021, Blood.

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

P. Chevallier, I. Yakoub-Agha, G. Guillerm, 2023, Bone Marrow Transplantation.

Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.

N. Ifrah, J. Harousseau, C. Linassier, 1999, Cancer.

Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations

V. Ugo, S. Thépot, M. Hunault, 2021, European journal of haematology.

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2009 .

Myelodysplastic Syndrome with t(5; 12)(q31;p 12‐p 13) and Eosinophilia: A Pediatric Case with Review of Literature

N. Ifrah, O. Blanchet, L. Baranger, 1996, Journal of pediatric hematology/oncology.

Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes

H. Tilly, X. Troussard, O. Hermine, 2000, Leukemia.

Hepatic hyper‐vitaminosis A: importance of retinyl ester level determination

N. Ifrah, F. Oberti, P. Calès, 2000, European journal of gastroenterology & hepatology.

Prophylactic or Preemptive Low-Dose Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Prevent Disease Relapse Following Allogeneic Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

P. Chevallier, S. Thépot, T. Guillaume, 2019, Blood.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.